Smartphone-Assisted Nanozyme Colorimetric Sensor Array Combined "Image Segmentation-Feature Extraction" Deep Learning for Detecting Unsaturated Fatty Acids.

Journal: ACS sensors
PMID:

Abstract

Conventional methods for detecting unsaturated fatty acids (UFAs) pose challenges for rapid analyses due to the need for complex pretreatment and expensive instruments. Here, we developed an intelligent platform for facile and low-cost analysis of UFAs by combining a smartphone-assisted colorimetric sensor array (CSA) based on MnO nanozymes with "image segmentation-feature extraction" deep learning (ISFE-DL). Density functional theory predictions were validated by doping experiments using Ag, Pd, and Pt, which enhanced the catalytic activity of the MnO nanozymes. A CSA mimicking mammalian olfactory system was constructed with the principle that UFAs competitively inhibit the oxidization of the enzyme substrate, resulting in color changes in the nanozyme-ABTS substrate system. Through linear discriminant analysis coupled with the smartphone App "Quick Viewer" that utilizes multihole parallel acquisition technology, oleic acid (OA), linoleic acid (LA), α-linolenic acid (ALA), and their mixtures were clearly discriminated; various edible vegetable oils, different camellia oils (CAO), and adulterated CAOs were also successfully distinguished. Furthermore, the ISFE-DL method was combined in multicomponent quantitative analysis. The sensing elements of the CSA (3 × 4) were individually segmented for single-hole feature extraction containing information from 38,868 images of three UFAs, thereby allowing for the extraction of more features and augmenting sample size. After training with the MobileNetV3 small model, the determination coefficients of OA, LA, and ALA were 0.9969, 0.9668, and 0.7393, respectively. The model was embedded in the smartphone App "Intelligent Analysis Master" for one-click quantification. We provide an innovative approach for intelligent and efficient qualitative and quantitative analysis of UFAs and other compounds with similar characteristics.

Authors

  • Xinyu Zhong
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Yuelian Qin
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Caihong Liang
    School of Materials Science and Engineering, Nanyang Technological University, 639798, Singapore.
  • Zhenwu Liang
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Yunyuan Nong
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Sanshan Luo
    Pharmaceutical College, Guangxi Medical University, Nanning 530021, China.
  • Yue Guo
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
  • Ying Yang
    Department of Endocrinology, The Affiliated Hospital of Yunnan University, Kunming, China.
  • Liuyan Wei
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Jinfeng Li
    Department of Radiology, First Medical Center, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, P. R. China.
  • Meiling Zhang
    Analytical and Testing Center of Wenzhou Medical University Wenzhou 325035, China.
  • Siqi Tang
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Yonghong Liang
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China.
  • Jinxia Wu
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China. Electronic address: jinxia-wu@sr.gxmu.edu.cn.
  • Yeng Ming Lam
    School of Materials Science and Engineering, Nanyang Technological University, 639798, Singapore; Facility for Analysis, Characterisation, Testing and Simulation (FACTS), Nanyang Technological University, 639798, Singapore. Electronic address: ymlam@ntu.edu.sg.
  • Zhiheng Su
    Pharmaceutical College, Guangxi Medical University, Nanning, 530021, China; Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning, 530021, China; Guangxi Beibu Gulf Marine Biomedicine Precision Development and High-value Utilization Engineering Research Center, Nanning, 530021, China; Guangxi Health Commission Key Laboratory of Basic Research on Antigeriatric Drugs, Nanning, 530021, China. Electronic address: suzhiheng915@126.com.